Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
This piece identifies funds with the highest management charges in the Dividend Aristocrats group and explains potential impact on performance.
26,423 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
Oil futures rose late Thursday as tensions in the Persian Gulf flared again, while stock-market futures were muted af...
Poly Truth is rolling out an AI-powered intelligence layer for prediction markets, promising data-driven insights on ...
As CME Group and ICE push 24/7 crypto trading, a heated clash with an offshore venue shines a spotlight on who contro...
As 2026 unfolds, retirees face tax and market challenges. A seasoned advisor outlines a tax-smart playbook for a $2 m...
PulsePlay tops Deloitte’s North American fastest-growing software list, catalyzing investor interest as users earn mo...
Two $2 trillion companies are anchoring Intel’s AI roadmap with a $5 billion NVIDIA investment and a multiyear Google...
When A-list decisions collide with pop culture, money follows. This piece breaks down the financial lessons behind a ...
When high-profile legal cases collide with everyday money, your finances can change fast. This guide uses the matthew...
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...